fbpx
El Dr. Ramón Cacabelos recibe el Premio Pasteur a la Excelencia Científica en Medicina Genómica y Neurociencias Clínicas

El pasado 23 de mayo, el Dr. Ramón Cacabelos, presidente y fundador de EuroEspes, fue distinguido con el…

“Solo el 30% de la población tiene un perfil genómico capaz de procesar bien el 80% de los fármacos”

Extracto de la edición impresa del periódico La Razón del viernes 22 de diciembre de 2023 EuroEspes es…

El Dr. Ramón Cacabelos recibe el Premio a la Trayectoria Profesional en Neurociencias y Medicina Genómica

Extracto de la edición impresa del periódico La Razón del Miércoles 4 de octubre de 2023 El Dr….

EuroEspes Health pone en marcha un Plan de Prevención Cerebral de ámbito nacional para empresas y colectivos de alto riesgo

Los accidentes cerebrovasculares y el ictus suponen un creciente desafío de salud Los accidentes cerebrovasculares y el ictus…

The importance of mental health

Intervention of Dr. Ramón Cacabelos at the round table organized by El Español.

Neurodegenerative diseases: the importance of genetics

Intervention of Dr. Ramón Cacabelos at the round table organized by El Español.

6,300 people a year are diagnosed with Alzheimer's disease and other dementias in our community.

Interview with Dr. Ramón Cacabelos in Galicia en la Onda on Onda Cero's "Galicia en la Onda" radio station.

Interview Dr. Cacabelos. Channel 24h of RTVE.

Interview Dr. Cacabelos. Channel 24h of RTVE.

Powerful epigenetic effect of Atremorine on Parkinson's and Alzheimer's disease

A study shows that in addition to a powerful epigenetic effect on Parkinson's disease, Atremorine shows a significant effect...

Genetic variants of the dopamine transporter influence pharmacological response in Parkinson's disease.

Study published in the international journal Drug Development Research shows that the effect of drugs for the treatment of Parkinson's...

Genomics and personalized treatment of chronic rhinosinusitis.

A study led by Dr. Joaquín Guerra, Head of the Neuro-Oto-Rhino-Laryngology Unit (UNOR) of the EuroEspes Medical Center, shows that there are...

EuroEspes Medical Center creates COVID-19 Advanced Prevention Protocol for companies

The EuroEspes Medical Center offers companies and their employees a home service for an ultra-rapid diagnosis of COVID-19...

Individual genetics determine the risk of covid-19 infection, the severity of the disease and which drug treatments may be most appropriate.

Studies carried out by different research groups, including EuroEspes, have concluded that genetics is evidence of an important...

European Patent Office grants patent to Spanish bioproduct for prevention and treatment of Parkinson's disease

Basic and clinical studies show that Atremorine prevents the premature death of dopaminergic neurons and improves the symptoms...

Dr. Ramón Cacabelos, President of EuroEspes, receives the European Award for Business Management and Innovation

In a ceremony held last Friday, October 19, at the Hotel Eurostars Suites Mirasierra and presented by journalist Ana García...

2018 Gallegos of the Year Awards Ceremony

Dr. Ramón Cacabelos, after the distinction granted in the previous edition, attended the "Gallegos del Año" awards ceremony...

Euroespes, A Tu Salud Award in Biotechnology Research

The Minister of Health, Ms. Carmen Montón, has presented Dr. Ramón Cacabelos with the A Tu Salud Award in Biotechnology Research....

Launch of MakaliSex, a new bioproduct for male sexual dysfunction

Scientists at the Biomedical Research Center, directed by Dr. Ramón Cacabelos, provide new solutions to sexual dysfunction...

EuroEspes Medical Center scientists present new models for the prevention and treatment of neurodegenerative and cardiovascular diseases

Scientific debate at the 8th Annual EuroEspes Conference, chaired by Dr. Ramón Cacabelos, Professor of Genomic Medicine and President...

U.S. Patent Office approves EuroEspes' EB101 vaccine for Alzheimer's disease

The U.S. Patent Office has just approved the EB101 vaccine against Alzheimer's disease developed by the Alzheimer's Disease Center in...

Atremorine, the new EuroEspes product that revolutionizes Parkinson's disease treatment

Recent data show the excellent properties of Atremorine in the prevention and treatment of Parkinson's disease...

Agreement for the implementation of Genomic Medicine in Iberoamerica

The Continental University of Peru and EuroEspes have signed a scientific and technical collaboration agreement for the implementation of programs...

New recognition for EuroEspes

The European Economic and Competitiveness Association has awarded the Gold Medal for Merit in the Workplace to the Biomedical Research Center...

High scientific representation of EuroEspes Medical Center at the World Congress of Biological Psychiatry in Denmark

A large group of scientists from the EuroEspes Biomedical Research Center are representing Spain at the World Congress of Psychiatry...

Mineraxin, a new nutraceutical with beneficial properties in perimenopause

Scientists at the Euroespes Biomedical Research Center have developed a new bioproduct with beneficial properties in perimenopausal stages of...

Privacy summary

In accordance with the provisions of Regulation (EU) 2016/679 on the protection of personal data of natural persons (RGPD), we inform you that the personal information you provide will be duly registered and incorporated into the data processing systems under the responsibility of:
Company Name: Euroespes S.A.
Commercial Name: EuroEspes S.A.
Registered Office: Santa Marta de Babio S/N - Bergondo (A Coruña)
CIF / NIF: A15319452
Telephone: 981780505
Fax: 981780511
e-Mail: info@euroespes.com
Registered in the Registry: R.M. of La Coruña, Volume 855, General Section, Folio 202, Page C-1635, Inscription 1ª.
Domain name: euroespes.com
Contact details of the Data Protection Delegate: delegado@euroespes.com